159922-50-6

Basic information

• Product Name: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE
• Synonyms: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE;4-Methoxyphenyl2,6-di-O-benzyl-b-D-galactopyranose;4-Methoxyphenyl 2,6-Di-O-benzyl-β-D-glucopyranoside;4-Methoxyphenyl 2,6-di-O-benzyl-b-D-galactopyranoside;4-Methoxyphenyl 2,6-Di-O-benzyl-β-D-galactopyranoside;4-Methoxyphenyl 2,6-Di-O-benzyl-β(2R,3R,4S,5R,6S)-5-(Benzyloxy)-2-((benzyloxy)methyl)-6-(4-methoxyphenoxy)tetrahydro-2H-pyran-3,4-diol
• CAS NO: 159922-50-6
• Molecular Formula: C₂₇H₃₀O₇
• Molecular Weight: 466.52
• Product Categories: Biochemistry;Galactose;Glycosides;O-Substituted Sugars;Sugars
• Mol File: 159922-50-6.mol
• Article Data: 5

Chemical Properties

• Melting Point: 113 °C
• Boiling Point: 641.144oC at 760 mmHg
• Flash Point: 341.552oC
• Appearance: /
• Density: 1.279g/cm3
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: -1 ° (C=1, CHCl3)
• Storage Temp.: Freezer
• Solubility: slightly sol. in Chloroform
• PKA: 12.83±0.70(Predicted)
• CAS DataBase Reference: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE(159922-50-6)
• EPA Substance Registry System: 4-METHOXYPHENYL 2,6-DI-O-BENZYL-BETA-D-GALACTOPYRANOSIDE(159922-50-6)

Safety Data

• Hazardous Substances Data: 159922-50-6(Hazardous Substances Data)

Usage

Chemical Properties

White to light yellow solid

InChI:InChI=1/C27H30O7/c1-30-21-12-14-22(15-13-21)33-27-26(32-17-20-10-6-3-7-11-20)25(29)24(28)23(34-27)18-31-16-19-8-4-2-5-9-19/h2-15,23-29H,16-18H2,1H3/t23-,24+,25+,26-,27-/m1/s1

Upstream product

• 100-39-0 benzyl bromide 
• 4163-60-4 β-D-galactose peracetate 
• 150-76-5 4-methoxy-phenol 
• 3150-20-7 4-methoxyphenyl β-D-galactopyranoside 
• 159922-67-5 4-methoxyphenyl 3,4-O-isopropylidene-β-D-galactopyranoside 
• 2872-65-3 4-methoxyphenyl 2,3,4,6-tetra-O-acetyl-β-D-galactopyranoside 
• 159922-68-6 4-methoxyphenyl 2,6-di-O-benzyl-3,4-O-isopropylidene-β-D-galactopyranoside 

Downstream Products

• 859505-01-4 4-methoxyphenyl 3,4,6-tri-O-acetyl-2-deoxy-2-phthalimido-β-D-galactopyranosyl-(1->3)-2,6-di-O-benzyl-β-D-galactopyranoside 
• 869107-20-0 Trifluoro-methanesulfonic acid (2R,3S,4R,5R,6S)-4,5-bis-benzyloxy-2-benzyloxymethyl-6-(4-methoxy-phenoxy)-tetrahydro-pyran-3-yl ester 
• 1104513-35-0 p-methoxyphenyl 4-O-acetyl-2,6-di-O-benzyl-β-D-galactopyranoside 
• 635684-68-3 4-methoxyphenyl 4-O-benzoyl-2,6-di-O-benzyl-β-D-galactopyranoside 

Relevant articles and documents

Total synthesis of sulfated glycosphingolipid SM1a, a kind of human epithelial carcinoma antigen

A highly efficient and practical total synthesis of the sulfated ganglioside SM1a, a kind of human epithelial carcinoma antigen identified in mammalian kidney, has been accomplished for the first time. The characteristic sequence of SM1a, β-D-Galp-(1→3)-β

Synthesis of some blocked di- and trisaccharide derivatives related to the repeating unit of the O-antigen from Shigella dysenteriae type 3 in the form of their glycosides

Starting from D-galactose and D-galactosamine hydrochloride, two new monosaccharide synthons namely 2-(trimethylsilyl)ethyl 4-O-acetyl-2,6-di-O- benzyl-β-D-galactopyranoside 2 and phenyl 3-O-acetyl-4,6-O-benzylidene-2- deoxy-2-phthalimido-1-thio-β-D-galac

SYNTHESIS OF HUMAN M BLOOD GROUP ANTIGENIC GLYCOPEPTIDE

A first total synthesis of terminal glycoheptapeptide of human glycophorin AM was accomplished by solution phase peptide condensation utilizing the tetrasaccharide-linked amino acid building blocks designed for Fmoc strategy.